Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease.
World journal of hepatology（2022）
摘要
One of every three patients with MAFLD had a high CVR, and in those with high fibrosis risk, the CVR risk was even greater.
更多查看译文
关键词
Cardiovascular risk,Fatty liver,Fibrosis,Hepatic steatosis,Liver disease
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要